Literature DB >> 17381549

Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts.

Erik R Westin1, Elizabeth Chavez, Kimberly M Lee, Francoise A Gourronc, Soraya Riley, Peter M Lansdorp, Frederick D Goldman, Aloysius J Klingelhutz.   

Abstract

Dyskeratosis congenita (DC), an inherited bone marrow failure syndrome, is caused by defects in telomerase. Somatic cells from DC patients have shortened telomeres and clinical symptoms are most pronounced in organs with a high cell turnover, including those involved in hematopoiesis and skin function. We previously identified an autosomal dominant (AD) form of DC that is caused by mutations in the telomerase RNA component (TER). In this study, we evaluated whether retroviral expression of TER and/or telomerase reverse transcriptase (TERT), the catalytic component of telomerase, could extend telomere length and rescue AD DC cells from a phenotype characteristic of early senescence. Exogenous TER expression, without TERT, could not activate telomerase in AD DC skin fibroblasts. Transduction of TERT alone, however, provided AD DC cells with sufficient telomerase activity to extend average telomere length and proliferative capacity. Interestingly, we found that expression of TER and TERT together resulted in extension of lifespan and higher levels of telomerase and longer telomeres than expression of TERT alone in both AD DC and normal cells. Our results provide evidence that AD DC cells can be rescued from defects in telomere maintenance and proliferation, and that coexpression of TERT and TER together provides a more efficient means to elongate telomeres than expression of TERT alone. Similar strategies may be useful for ameliorating the detrimental effects of telomere shortening in AD DC and other diseases associated with telomerase or telomere defects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17381549      PMCID: PMC2225626          DOI: 10.1111/j.1474-9726.2007.00288.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  65 in total

1.  Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells.

Authors:  J C Y Wang; J K Warner; N Erdmann; P M Lansdorp; L Harrington; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

2.  Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a.

Authors:  Viktor Janzen; Randolf Forkert; Heather E Fleming; Yoriko Saito; Michael T Waring; David M Dombkowski; Tao Cheng; Ronald A DePinho; Norman E Sharpless; David T Scadden
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

3.  Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.

Authors:  Ling-Yang Hao; Mary Armanios; Margaret A Strong; Baktiar Karim; David M Feldser; David Huso; Carol W Greider
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

4.  Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita.

Authors:  Judy M Y Wong; Kathleen Collins
Journal:  Genes Dev       Date:  2006-10-02       Impact factor: 11.361

5.  Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect.

Authors:  G Wang; V Slepushkin; J Zabner; S Keshavjee; J C Johnston; S L Sauter; D J Jolly; T W Dubensky; B L Davidson; P B McCray
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  Functional characterization of natural telomerase mutations found in patients with hematologic disorders.

Authors:  Zhong-Tao Xin; Adam D Beauchamp; Rodrigo T Calado; Jennifer W Bradford; Joshua A Regal; Aarthi Shenoy; Yuying Liang; Peter M Lansdorp; Neal S Young; Hinh Ly
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

7.  The effect of TERC haploinsufficiency on the inheritance of telomere length.

Authors:  Fred Goldman; Rachida Bouarich; Shashikant Kulkarni; Sara Freeman; Hong-Yan Du; Lea Harrington; Philip J Mason; Arturo Londoño-Vallejo; Monica Bessler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

8.  Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.

Authors:  Mary Armanios; Jiunn-Liang Chen; Yen-Pei Christy Chang; Robert A Brodsky; Anita Hawkins; Constance A Griffin; James R Eshleman; Alan R Cohen; Aravinda Chakravarti; Ada Hamosh; Carol W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

9.  Methylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells.

Authors:  B W Darbro; K M Lee; N K Nguyen; F E Domann; A J Klingelhutz
Journal:  Oncogene       Date:  2006-06-12       Impact factor: 9.867

10.  Telomere length homeostasis requires that telomerase levels are limiting.

Authors:  Gaël Cristofari; Joachim Lingner
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

View more
  35 in total

Review 1.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

2.  Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.

Authors:  Neha Nagpal; Jianing Wang; Jing Zeng; Emily Lo; Diane H Moon; Kevin Luk; Roman O Braun; Lauri M Burroughs; Sioban B Keel; Christopher Reilly; R Coleman Lindsley; Scot A Wolfe; Albert K Tai; Patrick Cahan; Daniel E Bauer; Yick W Fong; Suneet Agarwal
Journal:  Cell Stem Cell       Date:  2020-04-21       Impact factor: 24.633

3.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

Review 4.  The potential of non-myeloablative heterochronous autologous hematopoietic stem cell transplantation for extending a healthy life span.

Authors:  Primož Rožman
Journal:  Geroscience       Date:  2018-06-14       Impact factor: 7.713

5.  Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.

Authors:  Diane H Moon; Matthew Segal; Baris Boyraz; Eva Guinan; Inga Hofmann; Patrick Cahan; Albert K Tai; Suneet Agarwal
Journal:  Nat Genet       Date:  2015-10-19       Impact factor: 38.330

6.  PCB153 reduces telomerase activity and telomere length in immortalized human skin keratinocytes (HaCaT) but not in human foreskin keratinocytes (NFK).

Authors:  P K Senthilkumar; L W Robertson; G Ludewig
Journal:  Toxicol Appl Pharmacol       Date:  2011-12-22       Impact factor: 4.219

7.  A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding.

Authors:  Baris Boyraz; Courtney M Bellomo; Mark D Fleming; Corey S Cutler; Suneet Agarwal
Journal:  Blood       Date:  2016-09-01       Impact factor: 22.113

8.  Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease.

Authors:  Baris Boyraz; Diane H Moon; Matthew Segal; Maud Z Muosieyiri; Asli Aykanat; Albert K Tai; Patrick Cahan; Suneet Agarwal
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

Review 9.  Dyskeratosis congenita as a disorder of telomere maintenance.

Authors:  Nya D Nelson; Alison A Bertuch
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

10.  Dyskeratosis Congenita Dermal Fibroblasts are Defective in Supporting the Clonogenic Growth of Epidermal Keratinocytes.

Authors:  Erin M Buckingham; Frederick D Goldman; Aloysius J Klingelhutz
Journal:  Aging Dis       Date:  2012-10-12       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.